EcoDrugPlus

Catechol-O-Methyltransferase B

Ensembl ID : ENSOMYG00000021878
Gene Symbol: COMTB
1 Cross references
205 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSOMYG00000021507
Gene Symbol: COMTB
1 Cross references
205 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSOMYG00000040372
Gene Symbol: CTSC
2 Cross references
232 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSOMYG00000040968
Gene Symbol: CTSC
1 Cross references
226 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSOMYG00000000261
Gene Symbol: CTSK
2 Cross references
230 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSOMYG00000011790
Gene Symbol: CTSK
1 Cross references
230 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSOMYG00000000224
Gene Symbol: CTSS
1 Cross references
229 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSOMYG00000011761
Gene Symbol: CTSS
1 Cross references
229 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSOMYG00000042030
Gene Symbol: CDC7
2 Cross references
207 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSOMYG00000011659
Gene Symbol: CHEK2
1 Cross references
198 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSOMYG00000002579
Gene Symbol: CHEK2
1 Cross references
199 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSOMYG00000064113
Gene Symbol: CCR9A
1 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).